Integrated MRI-RT platforms offer precise and effective visualization of patient’s anatomical and physiological changes; that results in greater procedural accuracy and improved therapeutic outcome
Integrated MRI-RT Systems Making Their Way in the Field Of Image-Guided Radiotherapy
Posted by
MarketsandMarkets on Feb 14, 2019 5:02:31 PM
0 Comments Click here to read/write comments
Topics: Medical Devices, Radiotherapy Market, MRI-RT Systems
Guardant Health and AstraZeneca to develop companion diagnostics (CDx) and liquid biopsy tests
Posted by
MarketsandMarkets on Dec 19, 2018 6:13:11 PM
On Dec 13, 2018 AstraZeneca, a global research based biopharmaceutical company, partnered with Guardant Health (US) for the development of CDx tests to commercialize AstraZeneca’s oncology portfolio including Tagrisso and Imfinzi. The CDx test is based on liquid biopsy platform supported by Guardant’s proprietary Digital Sequencing technology.
0 Comments Click here to read/write comments
Topics: Medical Devices, blood-based companion diagnostics, cancer therapies, liquid biopsy, healthcare, tumor mutational burden